![Konrad Reinhart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Konrad Reinhart
Directeur/Bestuurslid bij Friedrich Schiller University of Jena
Profiel
Konrad Reinhart is Founder of SIRS-Lab GmbH.
He is Director of the Clinic for Anaesthesiology and Intensive Therapy at the University of Jena, President of the German Sepsis Society and a Director of the International Sepsis Forum.
Dr. Reinhart was appointed as Council Member of the World Federation Societies of Intensive and Critical Care Medicine in 2005.
He was Secretary of the European Society of Intensive Care Medicine.
Actieve functies van Konrad Reinhart
Bedrijven | Functie | Begin |
---|---|---|
Friedrich Schiller University of Jena | Directeur/Bestuurslid | - |
Eerdere bekende functies van Konrad Reinhart
Bedrijven | Functie | Einde |
---|---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
SIRS-Lab GmbH
![]() SIRS-Lab GmbH Medical SpecialtiesHealth Technology SIRS-Lab GmbH focuses on the development and commercialization of solutions for identification and detection of pathogens and antibiotic resistances. The company offers VYOO sepsis test that detects various bacterial and fungal species that cause sepsis, and LOOXSTER, which concentrates bacterial and fungal DNA contained in DNA-preparations, such as whole blood or ascites. It also provides gene expression services. SIRS-Lab was founded in 2000 by Stefan Russwurm, Eberhard Straube, Konrad Reinhart, and Hans Peter Saluz and is headquartered in Jena, Germany. | Health Technology |